Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Sino Biological launches European newsletter campaign with exclusive welcome gifts

13

Aug 2026

Sino Biological launches European newsletter campaign with exclusive welcome gifts

Sino Biological has launched a special Newsletter Registration Campaign exclusively for customers in Europe, offering researchers and life science professionals an exciting opportunity to stay connected with the latest scientific updates while receiving a complimentary welcome gift, which may be an adorable Snail Plushie Set or an Amazon Gift Card.

Your social life may leave a mark on how fast you age

12

Aug 2026

Your social life may leave a mark on how fast you age

Positive social experiences were associated with longer survival, while childhood adversity predicted shorter survival in a 1,309-person longitudinal cohort followed for nearly 15 years. Epigenetic aging, particularly GrimAge2, emerged as the strongest potential pathway linking social experiences with mortality risk.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.